Crescent Capital BDC, Inc. $CCAP Stock Sold by Fidelity National Financial Inc.

Fidelity National Financial Inc. decreased its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report) by 12.5% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,680,307 shares of the company’s stock after selling 525,000 shares during the period. Crescent Capital BDC comprises about 1.3% of Fidelity National Financial Inc.’s investment portfolio, making the stock its 3rd largest holding. Fidelity National Financial Inc. owned 0.10% of Crescent Capital BDC worth $33,785,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Integrated Wealth Concepts LLC acquired a new position in shares of Crescent Capital BDC in the 2nd quarter worth approximately $60,000. Beacon Pointe Advisors LLC bought a new stake in Crescent Capital BDC during the 2nd quarter worth approximately $111,000. Engineers Gate Manager LP bought a new stake in Crescent Capital BDC during the 2nd quarter worth approximately $114,000. Beaumont Financial Advisors LLC bought a new stake in Crescent Capital BDC during the 1st quarter worth approximately $127,000. Finally, SMH Capital Advisors Inc. acquired a new stake in Crescent Capital BDC during the 3rd quarter valued at $143,000. Institutional investors own 49.46% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CCAP. Raymond James Financial set a $10.00 price objective on Crescent Capital BDC in a research report on Thursday, October 22nd. Keefe, Bruyette & Woods lowered Crescent Capital BDC from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $13.00 to $12.00 in a research note on Monday, August 17th. Wells Fargo & Company decreased their target price on Crescent Capital BDC from $11.00 to $10.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 11th. B. Riley Financial lowered their target price on Crescent Capital BDC from $13.50 to $12.50 and set a “neutral” rating for the company in a research note on Wednesday, August 12th. Finally, Wall Street Zen raised Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, October 10th. Seven research analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Crescent Capital BDC currently has a consensus rating of “Hold” and a consensus price target of $11.54.

Read Our Latest Stock Analysis on CCAP

Insider Activity at Crescent Capital BDC

In other news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of Crescent Capital BDC stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $10.23, for a total value of $1,422,522.42. Following the completion of the sale, the insider directly owned 3,680,307 shares of the company’s stock, valued at approximately $37,649,540.61. This trade represents a 3.64% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 451,543 shares of company stock valued at $4,689,738. 1.23% of the stock is currently owned by company insiders.

Crescent Capital BDC Price Performance

CCAP opened at $10.13 on Monday. Crescent Capital BDC, Inc. has a one year low of $8.40 and a one year high of $15.18. The company’s 50 day simple moving average is $9.43 and its 200-day simple moving average is $11.47. The stock has a market capitalization of $373.25 million, a P/E ratio of -1,013.00 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last posted its quarterly earnings data on Monday, November 9th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. Crescent Capital BDC had a negative net margin of 0.10% and a positive return on equity of 8.74%. The firm had revenue of $36.89 million during the quarter, compared to analysts’ expectations of $36.37 million. As a group, analysts anticipate that Crescent Capital BDC, Inc. will post 1.45 EPS for the current year.

Crescent Capital BDC Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Thursday, December 31st will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 13.4%. The ex-dividend date is Thursday, December 31st. Crescent Capital BDC’s dividend payout ratio (DPR) is presently -13,600.00%.

Crescent Capital BDC Company Profile

(Free Report)

Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market businesses. It is externally managed by Crescent Capital Group LP, an alternative credit investment manager. The company invests primarily in debt, including first- and second-lien senior secured loans and subordinated debt, and may also make equity investments. Its portfolio focuses mainly on U.S. companies. Crescent Capital BDC began investment operations in 2015. Through its financing activities, it aims to support the business needs of middle-market companies, including growth and other strategic initiatives.

See Also

Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report).

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.